title: In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.
abstract: The objective of the present study is to compare the guar gum-based colon-targeted tablets of 5-fluorouracil against an immediate release tablet by in vitro dissolution and in vivo pharmacokinetic studies in human volunteers. Twelve healthy volunteers participated in the study. 5-Fluorouracil was administered at a dose of 50 mg both in immediate release tablet and colon-targeted tablet. On oral administration of colon-targeted tablets, 5-fluorouracil started appearing in the plasma at 6 h, and reached the peak concentration (C(max) of 216+/-15 ng/ml) at 7.6+/-0.1 h (T(max)), whereas the immediate release tablets produced peak plasma concentration (C(max) of 278+/-21 ng/ml) at 0.6+/-0.01 h (T(max)). The AUC(0- infinity ) for 5-fluorouracil from colon-targeted tablet and immediate release tablet were found to be 617+/-39 and 205+/-21 ng/ml/h, respectively. Colon-targeted tablets showed delayed t(max), delayed absorption time (t(a)), decreased C(max) and decreased absorption rate constant when compared to the immediate release tablets. The results of the study indicated that the guar gum-based colon-targeted formulation did not release the drug in stomach and small intestine, but delivered it to the colon resulting in a slow absorption of the drug and making it available for local action in colon.
authors.affiliation: Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, 530 003, India. krishnaysr112@rediffmail.com
authors.forename: Y S R
authors.initials: YS
authors.lastname: Krishnaiah
authors.forename: V
authors.initials: V
authors.lastname: Satyanarayana
authors.forename: B
authors.initials: B
authors.lastname: Dinesh Kumar
authors.forename: R S
authors.initials: RS
authors.lastname: Karthikeyan
authors.forename: P
authors.initials: P
authors.lastname: Bhaskar
mesh_terms: D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D019540:Area Under Curve; D002851:Chromatography, High Pressure Liquid; D003106:Colon / Q000378:metabolism*; D016503:Drug Delivery Systems; D005079:Excipients; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005685:Galactans; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008351:Mannans; D053149:Plant Gums; D012995:Solubility; D013607:Tablets
chemical_list: D000964:Antimetabolites, Antineoplastic; D005079:Excipients; D005685:Galactans; D008351:Mannans; D053149:Plant Gums; D013607:Tablets; C007894:guar gum; D005472:Fluorouracil